InvestSMART

Dotz Nano Limited (ASX: DTZ) - Announcements

Current share price for DTZ : $0.018 0.004 (18.18%)+

ASX company news and announcements for Dotz Nano Limited (DTZ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dotz Nano Limited (DTZ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dotz Nano Limited (DTZ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dotz Nano Limited (DTZ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$14 Notice of Annual General Meeting/Proxy Form - Full Document 1 Jul 2021 4:09PM $0.340 $0.018 fallen by 94.71%
$14 Notice of Annual General Meeting/Proxy Form 1 Jul 2021 4:08PM $0.340 $0.018 fallen by 94.71%
$14 Notification of cessation of securities - DTZ 1 Jul 2021 8:27AM $0.340 $0.018 fallen by 94.71%
$14 Notification of cessation of securities - DTZ 30 Jun 2021 10:39AM $0.330 $0.018 fallen by 94.55%
$14 Change in substantial holding - SIBF 27 May 2021 11:14AM $0.320 $0.018 fallen by 94.38%
$14 Appendix 3G 26 May 2021 4:43PM $0.320 $0.018 fallen by 94.38%
$14 Initial Director's Interest Notice - GB 20 May 2021 11:36AM $0.295 $0.018 fallen by 93.90%
$14 Final Director's Interest Notice - JC 20 May 2021 11:33AM $0.295 $0.018 fallen by 93.90%
$14 Garry Browne AM appointed to the Dotz Board 20 May 2021 9:53AM $0.295 $0.018 fallen by 93.90%
$14 Cancellation of Unquoted Options 10 May 2021 10:08AM $0.300 $0.018 fallen by 94%
$14 Appendix 2A 10 May 2021 8:35AM $0.325 $0.018 fallen by 94.46%
$14 Appendix 2A 5 May 2021 10:07AM $0.340 $0.018 fallen by 94.71%
$14 Proposed issue of Securities - DTZ 5 May 2021 9:39AM $0.340 $0.018 fallen by 94.71%
$14 Cleansing Prospectus 5 May 2021 9:21AM $0.340 $0.018 fallen by 94.71%
$14 Appendix 3G 3 May 2021 4:45PM $0.350 $0.018 fallen by 94.86%
$14 Quarterly Report & Appendix 4C Cashflow Report - 31 March 21 3 May 2021 9:19AM $0.355 $0.018 fallen by 94.93%
$14 Dotz and Zohar Dalia Sign Supply and Distribution Agreements 26 Apr 2021 9:16AM $0.360 $0.018 fallen by 95%
$14 DTZ Completes Clinical Trial and Submits FDA EUA Application 7 Apr 2021 10:13AM $0.390 $0.018 fallen by 95.38%
$14 Appendix 4G 31 Mar 2021 3:47PM $0.340 $0.018 fallen by 94.71%
$14 Full Year Statutory Accounts - 31 December 2020 31 Mar 2021 3:46PM $0.340 $0.018 fallen by 94.71%
$14 DTZ obtains CE for saliva-based virus detection technology 22 Mar 2021 10:00AM $0.275 $0.018 fallen by 93.45%
$14 Appendix 3G 19 Mar 2021 10:30AM $0.260 $0.018 fallen by 93.08%
$14 Vesting and Issue of Unquoted Options 17 Mar 2021 4:09PM $0.260 $0.018 fallen by 93.08%
$14 Proposed issue of Securities - DTZ 17 Mar 2021 4:06PM $0.260 $0.018 fallen by 93.08%
$14 Reinstatement to Official Quotation- 15 March 2021 12 Mar 2021 7:18PM $0.240 $0.018 fallen by 92.50%

451 - 475 of 817 results

Page 19 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.